PEAR THERAPEUTICS INC's ticker is and the CUSIP is 704723105. A total of 26 filers reported holding PEAR THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 2.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $633,286 | -69.7% | 2,483,472 | +40.2% | 0.00% | – |
| Q4 2022 | $2,089,806 | -68.2% | 1,771,022 | -45.1% | 0.00% | – |
| Q3 2022 | $6,581,000 | +301.3% | 3,226,467 | +203.0% | 0.00% | – |
| Q2 2022 | $1,640,000 | -68.9% | 1,064,709 | +1.8% | 0.00% | – |
| Q1 2022 | $5,280,000 | +36.8% | 1,045,443 | +67.9% | 0.00% | – |
| Q4 2021 | $3,860,000 | – | 622,639 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Arboretum Ventures, Inc. | 10,859,050 | $54,838,000 | 44.55% |
| 5AM Venture Management, LLC | 18,631,771 | $94,090,000 | 20.55% |
| TB Alternative Assets Ltd. | 2,071,865 | $10,463,000 | 3.59% |
| Palantir Technologies Inc. | 1,000,000 | $5,050,000 | 2.06% |
| SB Global Advisers Ltd | 12,100,078 | $61,105,000 | 1.92% |
| EDBI Pte Ltd | 427,070 | $2,157,000 | 1.44% |
| Temasek Holdings (Private) Ltd | 26,803,573 | $135,358,044 | 0.57% |
| Blue Water Life Science Advisors, LP | 194,686 | $983,000 | 0.47% |
| Sarissa Capital Management LP | 500,356 | $2,527,000 | 0.24% |
| Perceptive Advisors | 926,232 | $4,677,000 | 0.09% |